Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic HyperplasiaPetra Leidinger, Eckart Meese, Lisa Milchram et al.|PLoS ONE|2015Cited by 17